chr17-2042207-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_080822.3(OVCA2):c.160C>T(p.Pro54Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000126 in 1,432,116 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_080822.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OVCA2 | NM_080822.3 | c.160C>T | p.Pro54Ser | missense_variant | 1/2 | ENST00000572195.3 | |
DPH1 | NM_001383.6 | c.*18+332C>T | intron_variant | ENST00000263083.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OVCA2 | ENST00000572195.3 | c.160C>T | p.Pro54Ser | missense_variant | 1/2 | 1 | NM_080822.3 | P1 | |
DPH1 | ENST00000263083.12 | c.*18+332C>T | intron_variant | 1 | NM_001383.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152140Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000395 AC: 2AN: 50582Hom.: 0 AF XY: 0.0000355 AC XY: 1AN XY: 28130
GnomAD4 exome AF: 0.000130 AC: 167AN: 1279860Hom.: 0 Cov.: 36 AF XY: 0.000128 AC XY: 80AN XY: 623068
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152256Hom.: 0 Cov.: 33 AF XY: 0.0000672 AC XY: 5AN XY: 74444
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 20, 2024 | The c.160C>T (p.P54S) alteration is located in exon 1 (coding exon 1) of the OVCA2 gene. This alteration results from a C to T substitution at nucleotide position 160, causing the proline (P) at amino acid position 54 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at